Recovering from cocaine: Insights from clinical and preclinical investigations

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 9, 2013, Pages 2037-2046

  Hanlon, Colleen A ^a,b   Beveridge, Thomas J R ^a   Porrino, Linda J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Abstinence; Addiction; Cocaine; Glutamate; Neuroimaging; White matter

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; NEUROTRANSMITTER;

BRAIN FUNCTION; CLINICAL RESEARCH; COCAINE DEPENDENCE; CONVALESCENCE; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG WITHDRAWAL; HUMAN; NERVOUS SYSTEM FUNCTION; NEUROIMAGING; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW;

ABSTINENCE; ADDICTION; COCAINE; GLUTAMATE; NEUROIMAGING; WHITE MATTER;

ANIMALS; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; DRUG EVALUATION, PRECLINICAL; DRUG-SEEKING BEHAVIOR; HUMANS; TREATMENT OUTCOME;

EID: 84888003470     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.04.007     Document Type: Review

References (105)

1. Angelucci F., Gruber S.H., El Khoury A., Tonali P.A., Mathe A.A. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain. Eur. Neuropsychopharmacol. 2007, 17:756-762.
2. Banks M.L., Negus S.S. Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Adv. Pharmacol. Sci. 2012, 2012:281768.
3. Barros-Loscertales A., Garavan H., Bustamante J.C., Ventura-Campos N., Llopis J.J., Belloch V., Parcet M.A., Avila C. Reduced striatal volume in cocaine-dependent patients. Neuroimage 2011, 56:1021-1026.
4. Bartzokis G., Beckson M., Lu P.H., Edwards N., Bridge P., Mintz J. Brain maturation may be arrested in chronic cocaine addicts. Biol. Psychiatry 2002, 51:605-611.
5. Bartzokis G., Beckson M., Lu P.H., Edwards N., Rapoport R., Wiseman E., Bridge P. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res. 2000, 98:93-102.
6. Berglind W.J., See R.E., Fuchs R.A., Ghee S.M., Whitfield T.W., Miller S.W., McGinty J.F. A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur. J. Neurosci. 2007, 26:757-766.
7. Berglind W.J., Whitfield T.W., LaLumiere R.T., Kalivas P.W., McGinty J.F. A single intra-PFC infusion of BDNF prevents cocaine-induced alterations in extracellular glutamate within the nucleus accumbens. J. Neurosci. 2009, 29:3715-3719.
8. Berman S.M., Voytek B., Mandelkern M.A., Hassid B.D., Isaacson A., Monterosso J., Miotto K., Ling W., London E.D. Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol. Psychiatry 2008, 13:897-908.
9. Beveridge T.J., Gill K.E., Hanlon C.A., Porrino L.J. Review. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2008, 363:3257-3266.
10. Beveridge T.J., Smith H.R., Nader M.A., Porrino L.J. Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys. Neuropsychopharmacology 2009, 34:1162-1171.
11. Black I.B. Trophic regulation of synaptic plasticity. J. Neurobiol. 1999, 41:108-118.
12. Bolla K., Ernst M., Kiehl K., Mouratidis M., Eldreth D., Contoreggi C., Matochik J., Kurian V., Cadet J., Kimes A., Funderburk F., London E. Prefrontal cortical dysfunction in abstinent cocaine abusers. J. Neuropsychiatry Clin. Neurosci. 2004, 16:456-464.
13. Bolla K.I., Eldreth D.A., London E.D., Kiehl K.A., Mouratidis M., Contoreggi C., Matochik J.A., Kurian V., Cadet J.L., Kimes A.S., Funderburk F.R., Ernst M. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 2003, 19:1085-1094.
14. Bongarzone E.R., Howard S.G., Schonmann V., Campagnoni A.T. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. J. Neurosci. 1998, 18:5344-5353.
15. Bradberry C.W. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J. Neurosci. 2000, 20:7109-7115.
16. Bradberry C.W., Barrett-Larimore R.L., Jatlow P., Rubino S.R. Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys. J. Neurosci. 2000, 20:3874-3883.
17. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 2005, 76:99-125.
18. Connolly C.G., Foxe J.J., Nierenberg J., Shpaner M., Garavan H. The neurobiology of cognitive control in successful cocaine abstinence. Drug Alcohol Depend. 2012, 121:45-53.
19. D'Sa C., Fox H.C., Hong A.K., Dileone R.J., Sinha R. Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study. Biol. Psychiatry 2011, 70:706-711.
20. Ersche K.D., Jones P.S., Williams G.B., Turton A.J., Robbins T.W., Bullmore E.T. Abnormal brain structure implicated in stimulant drug addiction. Science 2012, 335:601-604.
21. Fein G., Di Sclafani V., Meyerhoff D.J. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend. 2002, 68:87-93.
22. Franklin T.R., Acton P.D., Maldjian J.A., Gray J.D., Croft J.R., Dackis C.A., O'Brien C.P., Childress A.R. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol. Psychiatry 2002, 51:134-142.
23. Gallo V., Zhou J.M., McBain C.J., Wright P., Knutson P.L., Armstrong R.C. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J. Neurosci. 1996, 16:2659-2670.
24. Garavan H., Hester R. The role of cognitive control in cocaine dependence. Neuropsychol. Rev. 2007, 17:337-345.
25. Gazdzinski S., Durazzo T.C., Meyerhoff D.J. Temporal dynamics and determinants of whole brain tissue volume changes during recovery from alcohol dependence. Drug Alcohol Depend. 2005, 78:263-273.
26. Gazdzinski S., Durazzo T.C., Studholme C., Song E., Banys P., Meyerhoff D.J. Quantitative brain MRI in alcohol dependence: preliminary evidence for effects of concurrent chronic cigarette smoking on regional brain volumes. Alcohol. Clin. Exp. Res. 2005, 29:1484-1495.
27. Goldstein R.Z., Leskovjan A.C., Hoff A.L., Hitzemann R., Bashan F., Khalsa S.S., Wang G.J., Fowler J.S., Volkow N.D. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 2004, 42:1447-1458.
28. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
29. Gottschalk C., Beauvais J., Hart R., Kosten T. Cognitive function and cerebral perfusion during cocaine abstinence. Am. J. Psychiatry 2001, 158:540-545.
30. Griffiths R.R., Wurster R.M., Brady J.V. Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin. Pharmacol. Rev. 1975, 27:357-365.
31. Griffiths R.R., Bigelow G.E., Henningfield J.E. Similarities in Animals and Human Drug-Taking Behavior 1980, JAI Press, Greenwich, CT.
32. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 2003, 23:742-747.
33. Gu H., Salmeron B.J., Ross T.J., Geng X., Zhan W., Stein E.A., Yang Y. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage 2010, 53:593-601.
34. Hall F.S., Drgonova J., Goeb M., Uhl G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 2003, 28:1485-1490.
35. Hanlon C.A., Dufault D.L., Wesley M.J., Porrino L.J. Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology (Berl) 2011, 218:681-692.
36. Hanlon C.A., Wesley M.J., Stapleton J.R., Laurienti P.J., Porrino L.J. The association between frontal-striatal connectivity and sensorimotor control in cocaine users. Drug Alcohol Depend. 2011, 115:240-243.
37. Hetherington H.P., Pan J.W., Telang F., Pappas N., Volkow N. Reduced brain GABA levels in cocaine abusers. Proc. Int. Soc. Magn. Reson. Med. 2000, 523.
38. Holman B.L., Mendelson J., Garada B., Teoh S.K., Hallgring E., Johnson K.A., Mello N.K. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. J. Nucl. Med. 1993, 34:723-727.
39. Howard S., Landry C., Fisher R., Bezouglaia O., Handley V., Campagnoni A. Postnatal localization and morphogenesis of cells expressing the dopaminergic D2 receptor gene in rat brain: expression in non-neuronal cells. J. Comp. Neurol. 1998, 391:87-98.
40. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991, 350:230-232.
41. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-Notestine C., Mindt M.R., Marcotte T.D., Heaton R.K., Ellis R.J., Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am. J. Psychiatry 2005, 162:1461-1472.
42. Jiang X., Zhou J., Mash D.C., Marini A.M., Lipsky R.H. Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution. Neuromol. Med. 2009, 11:1-12.
43. Johanson C.E. Pharmacological and environmental variables affecting drug preference in rhesus monkeys. Pharmacol. Rev. 1975, 27:343-355.
44. Johanson C.E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 1989, 41:3-52.
45. Kalivas P.W. Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox. Res. 2008, 14:185-189.
46. Kalivas P.W., Volkow N.D. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol. Psychiatry 2011, 16:974-986.
47. Kampman K.M., Volpicelli J.R., Mulvaney F., Rukstalis M., Alterman A.I., Pettinati H., Weinrieb R.M., O'Brien C.P. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict. Behav. 2002, 27:251-260.
48. Ke Y., Streeter C.C., Nassar L.E., Sarid-Segal O., Hennen J., Yurgelun-Todd D.A., Awad L.A., Rendall M.J., Gruber S.A., Nason A., Mudrick M.J., Blank S.R., Meyer A.A., Knapp C., Ciraulo D.A., Renshaw P.F. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res. 2004, 130:283-293.
49. Kelly C., Zuo X.N., Gotimer K., Cox C.L., Lynch L., Brock D., Imperati D., Garavan H., Rotrosen J., Castellanos F.X., Milham M.P. Reduced interhemispheric resting state functional connectivity in cocaine addiction. Biol. Psychiatry 2011, 69:684-692.
50. Kolb B., Gorny G., Li Y., Samaha A.N., Robinson T.E. Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10523-10528.
51. Lenoir M., Serre F., Cantin L., Ahmed S.H. Intense sweetness surpasses cocaine reward. PLoS ONE 2007, 2:e698.
52. Letchworth S.R., Nader M.A., Smith H.R., Friedman D.P., Porrino L.J. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 2001, 21:2799-2807.
53. Li Y., Kolb B., Robinson T.E. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 2003, 28:1082-1085.
54. Licata S.C., Renshaw P.F. Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann. N. Y. Acad. Sci. 2010, 1187:148-171.
55. Liu X., Matochik J.A., Cadet J.L., London E.D. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology 1998, 18:243-252.
56. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Bramen J., Shinn A.K., Miotto K., Learn J., Dong Y., Matochik J.A., Kurian V., Newton T., Woods R., Rawson R., Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch. Gen. Psychiatry 2004, 61:73-84.
57. Ma L., Hasan K.M., Steinberg J.L., Narayana P.A., Lane S.D., Zuniga E.A., Kramer L.A., Moeller F.G. Diffusion tensor imaging in cocaine dependence: regional effects of cocaine on corpus callosum and effect of cocaine administration route. Drug Alcohol Depend. 2009, 104:262-267.
58. Ma N., Liu Y., Li N., Wang C.X., Zhang H., Jiang X.F., Xu H.S., Fu X.M., Hu X., Zhang D.R. Addiction related alteration in resting-state brain connectivity. Neuroimage 2010, 49:738-744.
59. Malison R.T., Best S.E., van Dyck C.H., McCance E.F., Wallace E.A., Laruelle M., Baldwin R.M., Seibyl J.P., Price L.H., Kosten T.R., Innis R.B. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am. J. Psychiatry 1998, 155:832-834.
60. Martinez D., Carpenter K.M., Liu F., Slifstein M., Broft A., Friedman A.C., Kumar D., Van Heertum R., Kleber H.D., Nunes E. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am. J. Psychiatry 2011, 168:634-641.
61. Martinez D., Narendran R., Foltin R.W., Slifstein M., Hwang D.R., Broft A., Huang Y., Cooper T.B., Fischman M.W., Kleber H.D., Laruelle M. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am. J. Psychiatry 2007, 164:622-629.
62. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., Fischman M.W., Laruelle M. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 2004, 29(June (6)):1190-1202.
63. Mash D.C., Pablo J., Ouyang Q., Hearn W.L., Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 2002, 81:292-300.
64. Mateo Y., Lack C.M., Morgan D., Roberts D.C., Jones S.R. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 2005, 30:1455-1463.
65. Matochik J.A., London E.D., Eldreth D.A., Cadet J.L., Bolla K.I. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 2003, 19:1095-1102.
66. McGinty J.F., Mendelson J.E. Is brain-derived neurotrophic factor a selective biomarker that predicts cocaine relapse outcomes?. Biol. Psychiatry 2011, 70:700-701.
67. Moeller F.G., Hasan K.M., Steinberg J.L., Kramer L.A., Dougherty D.M., Santos R.M., Valdes I., Swann A.C., Barratt E.S., Narayana P.A. Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology 2005, 30:610-617.
68. Nader M.A., Daunais J.B., Moore T., Nader S.H., Moore R.J., Smith H.R., Friedman D.P., Porrino L.J. Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 2002, 27:35-46.
69. Nader M.A., Morgan D., Gage H.D., Nader S.H., Calhoun T.L., Buchheimer N., Ehrenkaufer R., Mach R.H. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat. Neurosci. 2006, 9:1050-1056.
70. Nader M.A., Sinnott R.S., Mach R.H., Morgan D. Cocaine- and food-maintained responding under a multiple schedule in rhesus monkeys: environmental context and the effects of a dopamine antagonist. Psychopharmacology (Berl) 2002, 163:292-301.
71. Nader M.A., Woolverton W.L. Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology (Berl) 1991, 105:169-174.
72. Narayana P.A., Ahobila-Vajjula P., Ramu J., Herrera J., Steinberg J.L., Moeller F.G. Diffusion tensor imaging of cocaine-treated rodents. Psychiatry Res. 2009, 171:242-251.
73. Nielsen D.A., Huang W., Hamon S.C., Maili L., Witkin B.M., Fox R.G., Cunningham K.A., Moeller F.G. Forced abstinence from cocaine self-administration is associated with DNA methylation changes in myelin genes in the corpus callosum: a preliminary study. Front. Psychiatry 2012, 3:60.
74. O'Neill J., Cardenas V.A., Meyerhoff D.J. Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging. Addict. Biol. 2001, 6:347-361.
75. Pfefferbaum A., Sullivan E.V., Mathalon D.H., Shear P.K., Rosenbloom M.J., Lim K.O. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol. Clin. Exp. Res. 1995, 19:1177-1191.
76. Pfefferbaum A., Sullivan E.V., Rosenbloom M.J., Mathalon D.H., Lim K.O. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch. Gen. Psychiatry 1998, 55:905-912.
77. Poling J., Kosten T.R., Sofuoglu M. Treatment outcome predictors for cocaine dependence. Am. J. Drug Alcohol Abuse 2007, 33:191-206.
78. Robinson T.E., Gorny G., Mitton E., Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001, 39:257-266.
79. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 1999, 11:1598-1604.
80. Sadri-Vakili G., Kumaresan V., Schmidt H.D., Famous K.R., Chawla P., Vassoler F.M., Overland R.P., Xia E., Bass C.E., Terwilliger E.F., Pierce R.C., Cha J.H. Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J. Neurosci. 2010, 30:11735-11744.
81. Samuvel D.J., Jayanthi L.D., Manohar S., Kaliyaperumal K., See R.E., Ramamoorthy S. Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 2008, 325:293-301.
82. Schmidt H.D., Sangrey G.R., Darnell S.B., Schassburger R.L., Cha J.H., Pierce R.C., Sadri-Vakili G. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J. Neurochem. 2012, 120:202-209.
83. Schuster C.R., Johanson C.E. An analysis of drug-seeking behavior in animals. Neurosci. Biobehav. Rev. 1981, 5:315-323.
84. Sim M.E., Lyoo I.K., Streeter C.C., Covell J., Sarid-Segal O., Ciraulo D.A., Kim M.J., Kaufman M.J., Yurgelun-Todd D.A., Renshaw P.F. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology 2007, 32:2229-2237.
85. Sinha R., Fox H., Hong K.I., Sofuoglu M., Morgan P.T., Bergquist K.T. Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse susceptibility. Exp. Clin. Psychopharmacol. 2007, 15:445-452.
86. Smith H.R., Wang S., Beveridge T.J.R., Porrino L.J. Evidence for inflammation in CNS white matter of monkeys following prolonged exposure to cocaine self-administration. Society for Neuroscience Annual Meeting 2011.
87. Smith H.R., Williams A., Beveridge T.J.R., Nader M.A., Porrino L.J. Disrupted glucose metabolism in central white matter fiber tracts following prolonged cocaine self-administration in nonhuman primates. Society for Neuroscience Annual Meeting 2012.
88. Staley J.K., Hearn W.L., Ruttenber A.J., Wetli C.V., Mash D.C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther. 1994, 271:1678-1685.
89. Stalnaker T.A., Takahashi Y., Roesch M.R., Schoenbaum G. Neural substrates of cognitive inflexibility after chronic cocaine exposure. Neuropharmacology 2009, 56(Suppl. 1):63-72.
90. Strickland T.L., Mena I., Villanueva-Meyer J., Miller B.L., Cummings J., Mehringer C.M., Satz P., Myers H. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J. Neuropsychiatry Clin. Neurosci. 1993, 5:419-427.
91. Tanabe J., Tregellas J.R., Dalwani M., Thompson L., Owens E., Crowley T., Banich M. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol. Psychiatry 2009, 65:160-164.
92. Vocci F.J. Can replacement therapy work in the treatment of cocaine dependence? And what are we replacing anyway?. Addiction 2007, 102:1888-1889.
93. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., Dewey S.L., Wolf A.P. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993, 14:169-177.
94. Volkow N.D., Fowler J.S., Wolf A.P. Use of positron emission tomography to study cocaine in the human brain. NIDA Res. Monogr. 1991, 112:168-179.
95. Volkow N.D., Fowler J.S., Wolf A.P., Hitzemann R., Dewey S., Bendriem B., Alpert R., Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am. J. Psychiatry 1991, 148:621-626.
96. Volkow N.D., Hitzemann R., Wang G.J., Fowler J.S., Wolf A.P., Dewey S.L., Handlesman L. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992, 11:184-190.
97. Volkow N.D., Mullani N., Gould K.L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br. J. Psychiatry 1988, 152:641-648.
98. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
99. Volkow N.D., Wang G.J., Ma Y., Fowler J.S., Wong C., Ding Y.S., Hitzemann R., Swanson J.M., Kalivas P. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J. Neurosci. 2005, 25:3932-3939.
100. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex 2000, 10(March (3)):318-325.
101. Wang G.J., Volkow N.D., Chang L., Miller E., Sedler M., Hitzemann R., Zhu W., Logan J., Ma Y., Fowler J.S. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am. J. Psychiatry 2004, 161:242-248.
102. Wheeler R.A., Carelli R.M. Dissecting motivational circuitry to understand substance abuse. Neuropharmacology 2009, 56(Suppl. 1):149-159.
103. Wolf M.E. The Bermuda Triangle of cocaine-induced neuroadaptations. Trends Neurosci. 2010, 33:391-398.
104. Yang S., Salmeron B.J., Ross T.J., Xi Z.X., Stein E.A., Yang Y. Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - a (1)H-MRS study using TE-averaged PRESS at 3T with an optimized quantification strategy. Psychiatry Res. 2009, 174:171-176.
105. Zhou W., Kalivas P.W. N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking. Biol. Psychiatry 2008, 63:338-340.